ReviewNPJ breast cancer2025

Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion.

Neil M Iyengar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.